Tieling Zhou

Tieling Zhou

Auto-generated profile, based on publicly available information

Tieling Zhou

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center; Houston, TX, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2024 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
ZRZahraa Rahal
Zahraa Rahal
YLYuejiang Liu
Yuejiang Liu
FPFuduan Peng
Fuduan Peng
SYSujuan Yang
Sujuan Yang
MJMohamed A. Jamal
Mohamed A. Jamal
HKHumam Kadara
Humam Kadara
Accumulating evidence indicates that the gut microbiome influences cancer progression and therapy. We recently showed that progressive changes in gut microbial diversity and composition are closely coupled with tobacco-associated lung adenocarcinoma in a human-relevant mouse model. Furthermore, we demonstrated that the loss of the antimicrobial protein Lcn2 in these mice exacerbates protumor inflammatory phenotypes while further reducing microbial diversity. Yet, how gut microbiome alterations impinge on lung adenocarcinoma development remains poorly understood. In this study, we investigated the role of gut microbiome changes in lung adenocarcinoma development using fecal microbiota transfer and delineated a pathway by which gut microbiome alterations incurred by loss of Lcn2 fostered the proliferation of proinflammatory bacteria of the genus Alistipes, triggering gut inflammation. This inflammation propagated systemically, exerting immunosuppression within the tumor microenvironment, augmenting tumor growth through an IL6-dependent mechanism and dampening response to immunotherapy. Corroborating our preclinical findings, we found that patients with lung adenocarcinoma with a higher relative abundance of Alistipes species in the gut showed diminished response to neoadjuvant immunotherapy. These insights reveal the role of microbiome-induced inflammation in lung adenocarcinoma and present new potential targets for interception and therapy.

28 May 2026 in Science
Verified
Journal Article
Closed access
KCKyung Serk Cho
Kyung Serk Cho
YLYunhe Liu
Yunhe Liu
GPGuangsheng Pei
Guangsheng Pei
JCJianfeng Chen
Jianfeng Chen
YDYibo Dai
Yibo Dai
LWLinghua Wang
Linghua Wang
Tertiary lymphoid structures (TLSs) are critical regulators of antitumor immunity, yet their spatial organization, maturation, and clinical relevance remain incompletely defined across cancers. We analyzed spatial transcriptomics spanning 12 cancer types to construct a pan-cancer TLS atlas and characterized TLS spatial architecture and maturation states. TLS maturation was accompanied by coordinated remodeling of distinct niche cell populations and distance-dependent gradients in tumor programs, orthogonally supported by ultrahigh-plex single-cell spatial profiling. To enable scalable TLS profiling, we trained an artificial intelligence framework that predicts TLS maturation states directly from hematoxylin and eosin–stained images and evaluated it across TCGA and independent therapy cohorts. We further derived a maturation-aware composite score capturing intratumoral TLS state composition, which robustly stratifies patients across cancer and treatment contexts, outperforming conventional TLS metrics.

24 January 2025 in Cancer Research
Verified
Journal Article
Open access
TVTanvi H. Visal
Tanvi H. Visal
RBRecep Bayraktar
Recep Bayraktar
PHPetra den Hollander
Petra den Hollander
MAMichael A. Attathikhun
Michael A. Attathikhun
TZTieling Zhou
Tieling Zhou
SMSendurai Mani
Sendurai Mani
Triple-negative breast cancer (TNBC) is a highly metastatic subtype of breast cancer. The epithelial-to-mesenchymal transition is a nonbinary process in the metastatic cascade that generates tumor cells with both epithelial and mesenchymal traits known as hybrid EM cells. Recent studies have elucidated the enhanced metastatic potential of cancers featuring the hybrid EM phenotype, highlighting the need to uncover molecular drivers and targetable vulnerabilities of the hybrid EM state. Here, we discovered that hybrid EM breast tumors are enriched in CD38, an immunosuppressive molecule associated with worse clinical outcomes in liquid malignancies. Altering CD38 expression in tumor cell impacted migratory, invasive, and metastatic capabilities of hybrid EM cells. Abrogation of CD38 expression stimulated an antitumor immune response, thereby preventing the generation of an immunosuppressive microenvironment in hybrid EM tumors. CD38 levels positively correlated with PD-L1 expression in samples from patients with TNBC. Moreover, targeting CD38 potentiated the activity of anti–PD-L1, eliciting strong antitumor immunity, with reduced tumor growth in hybrid EM models. Overall, this research exposes upregulation of CD38 as a specific survival strategy utilized by hybrid EM breast tumors to suppress immune cell activity and sustain metastasis, with strong implications in other carcinomas that have hybrid EM properties. Significance: Hybrid cells co-featuring epithelial and mesenchymal traits in triple-negative breast cancer express elevated levels of CD38 to induce immunosuppression and metastasis, indicating CD38 inhibition as potential strategy for treating breast cancer.

17 June 2026
Verified
Other
Open access
ZRZahraa Rahal
Zahraa Rahal
YLYuejiang Liu
Yuejiang Liu
FPFuduan Peng
Fuduan Peng
SYSujuan Yang
Sujuan Yang
MJMohamed A. Jamal
Mohamed A. Jamal
HKHumam Kadara
Humam Kadara
Comparative analysis of microbial abundance in tumor tissue samples across FMT groups.

17 June 2026
Verified
Other
Open access
ZRZahraa Rahal
Zahraa Rahal
YLYuejiang Liu
Yuejiang Liu
FPFuduan Peng
Fuduan Peng
SYSujuan Yang
Sujuan Yang
MJMohamed A. Jamal
Mohamed A. Jamal
HKHumam Kadara
Humam Kadara
LEfSe analysis of differential abundance across groups.

17 June 2026
Verified
Other
Open access
ZRZahraa Rahal
Zahraa Rahal
YLYuejiang Liu
Yuejiang Liu
FPFuduan Peng
Fuduan Peng
SYSujuan Yang
Sujuan Yang
MJMohamed A. Jamal
Mohamed A. Jamal
HKHumam Kadara
Humam Kadara
Table S1 from Inflammation Mediated by Gut Microbiome Alterations Promotes Lung Cancer Development and an Immunosuppressed Tumor Microenvironment